Ultrasound Guided Foam Sclerotherapy for the Management of Recurrent Varicose Veins



  1. 1.
    Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther. 2006;13:357–64.CrossRefPubMedGoogle Scholar
  2. 2.
    Perrin MR, Guex JJ, Ruckley CV, et al. Recurrent varices after surgery (REVAS), a consensus document. Cardiovasc Surg. 2000;8(4):233–45.CrossRefPubMedGoogle Scholar
  3. 3.
    Perrin MR. Presence of varicies after operative treatment; a review. Phlebolymphology. 2014;21(3):158–68.Google Scholar
  4. 4.
    Mendoza E, Lattimer CR, Morrison N. Duplex ultrasound of superficial leg veins. London: Springer-Verlag; 2014. ISBN: 978-3642407307CrossRefGoogle Scholar
  5. 5.
    Fischer R, Linde N, Duff C, Jeanneret C, Chandler JG, Seeber P. Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein. J Vasc Surg. 2001;34:236–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Winterborn RJ, Foy C, Earnshaw JJ. Causes of varicose vein recurrence: late results of a randomized controlled trial of stripping the long saphenous vein. J Vasc Surg. 2004;40:634–9.CrossRefPubMedGoogle Scholar
  7. 7.
    McMurrich JP. The occurrence of congenital adhesions in the common iliac veins, and their relation to thrombosis of the femoral and iliac veins. Am J Med Sci. 1908;135:342–6.CrossRefGoogle Scholar
  8. 8.
    May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–27.CrossRefPubMedGoogle Scholar
  9. 9.
    Cockett FB, Thomas ML. The iliac compression syndrome. Br J Surg. 1965;52:816–21.CrossRefPubMedGoogle Scholar
  10. 10.
    Allan JC. Volume changes in the lower limb in response to postural alterations and muscular exercise. S Afr J Surg. 1964;2:75–90.Google Scholar
  11. 11.
    Lattimer CR, Mendoza E. Reappraisal of the utility of the tilt-table in the investigation of venous disease. Eur J Vasc Endovasc Surg. 2016;52(6):854–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Lattimer CR, Mendoza E, Kalodiki E. The current status of air-plethysmography in evaluating non-thrombotic iliac vein lesions. Phlebology. 2017.; doi: 10.1177/0268355516687866. [Epub ahead of print]. PMID: 28056700Google Scholar
  13. 13.
    Kundu S, Lurie F, Millward SF, et al. Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: Joint Statement of the American Venous Forum and the Society of Interventional Radiology. J Vasc Surg. 2007;46:582–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Smith JJ, Garratt AM, Guest M, Greenhalgh RM, Davies AH. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg. 1999;30:710–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Watkins MR. Deactivation of sodium tetradecyl sulphate injection by blood proteins. Eur J Vasc Endovasc Surg. 2011;41(4):521–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Breu FX, Guggenbichler S, Wollmann JC. Second European consensus meeting on foam sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37(71):1–29.PubMedGoogle Scholar
  17. 17.
    Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy, April, 4–6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30(5):709–17.CrossRefPubMedGoogle Scholar
  18. 18.
    Gillet JL, Guedes JM, Guex JJ, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology. 2009;24:131–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Morrison N, Cavezza A, Bergan J, Partsch H. Regarding ‘stroke after varicose vein foam injection sclerotherapy’. J Vasc Surg. 2006;44:224–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27:58–60.PubMedGoogle Scholar
  21. 21.
    Parsi K. Catheter-directed sclerotherapy. Phlebology. 2009;24:98–107.CrossRefPubMedGoogle Scholar
  22. 22.
    Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg. 2008;47:830–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg. 2009;37(3):343–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Parsi K, Exner T, Connor DE, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg. 2007;34:731–40.CrossRefPubMedGoogle Scholar
  25. 25.
    Scurr JH, Coleridge-Smith P, Cutting P. Varicose veins: optimum compression following sclerotherapy. Ann Royal Coll Surg Eng. 1985;67:109–11.Google Scholar
  26. 26.
    Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.CrossRefPubMedGoogle Scholar
  27. 27.
    Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31(6):1307–12.CrossRefPubMedGoogle Scholar
  28. 28.
    Van Bellen B, Gross WS, Verta MJ Jr, Yao JS, Bergan J. Lymphatic disruption in varicose vein surgery. Surgery. 1977;82(2):257–9.PubMedGoogle Scholar
  29. 29.
    Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94:925–36.CrossRefPubMedGoogle Scholar
  30. 30.
    Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20.CrossRefPubMedGoogle Scholar
  31. 31.
    Hansen K, Morrison N, Neuhardt DL, Salles-Cunha SX. Transthoracic echocardiogram and transcranial Doppler detection of emboli after foam sclerotherapy of leg veins. J Vasc Ultrasound. 2007;31(4):213–6.CrossRefGoogle Scholar
  32. 32.
    Kalodiki E, Azzam M, Geroulakos G, Lattimer CR. Hemodynamic outcomes at 5 years from a randomized controlled trial comparing laser ablation with foam sclerotherapy. J Vasc Surg Venous Lymphat Disord. 2017;5(1):161.e6.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Christopher Richard Lattimer
    • 1
    • 2
  • Mustapha Azzam
    • 1
    • 2
  1. 1.Josef Pflug Vascular LaboratoryEaling Hospital NHS TrustMiddlesexUK
  2. 2.Imperial College, West London Vascular and Interventional CentreLondonUK

Personalised recommendations